malleable penile prosthesis for treatment of erectile dysfunction

Malleable penile prosthesis predictors of success and patient satisfaction

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202206546247568

Enrollment

Registered

2022-06-21

Start date

2022-07-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urological and Genital Diseases

Interventions

malleable penile prosthesis implantation

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: • Sexually active male patients (20-70) years old. • International index of erectile function (IIEF=1-16). • Cardiac patients with contraindications for the use of PDE5Is • Patients who need high doses of PDE5Is to achieve an erection. • Advanced Peyronie’s Disease • Priapism • Following penile or pelvic trauma or surgery

Exclusion criteria

Exclusion criteria: • Active infection anywhere in the body, particularly urinary tract or genital infection • Unresolved problems of urination such as elevated residual urine volume secondary to the neurogenic bladder or bladder outlet obstruction (BPE) • Patients not willing to go for device revision surgery

Design outcomes

Primary

Measure	Time frame
efficacy of different techniques in the malleable penile prosthesis implantation, its effect on patient satisfaction, and predictors of success	—

Secondary

Measure	Time frame
to detect complications and their pre and intra-operative predictors	—

Countries

Egypt

Contacts

Public Contacthazem elmoghazy

associate professor of urology faculty of medicine sohag university

moghazyh@gmail.com00201096522289

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026